These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 6104680)
1. Effect of the somatostatin analog D-Trp8,D-Cys14 on glucose insulin, pancreatic glucagon and growth hormone plasma levels in acromegalics and mild diabetics. Trovati M; Massara F; Camanni F; Molinatti GM; Lorenzati R; Pagano GF J Endocrinol Invest; 1980; 3(2):189-92. PubMed ID: 6104680 [TBL] [Abstract][Full Text] [Related]
2. Dissociated effects of somatostatin analogs on arginine-induced insulin, glucagon and growth hormone release in acromegalic patients. Wajchenberg BL; Cesar FP; Leme CE; Borghi VC; Souza VC; Souza IT; Neto DG; Germek OA; Coy DH; Comaru-Schally AM Horm Metab Res; 1983 Oct; 15(10):471-4. PubMed ID: 6139329 [TBL] [Abstract][Full Text] [Related]
3. The inhibitory effect of somatostatin on growth hormone, insulin and glucagon secretion in diabetes mellitus. Ward FR; Leblanc H; Yen SS J Clin Endocrinol Metab; 1975 Sep; 41(3):527-32. PubMed ID: 1159060 [TBL] [Abstract][Full Text] [Related]
4. D-Trp8-D-Cys14-somatostatin--demonstration of its differential suppressive activity in juvenile diabetics. Neuhaus C; Kerner W; Maier V; Pfeiffer EF Horm Metab Res Suppl; 1979; (8):115-8. PubMed ID: 395066 [TBL] [Abstract][Full Text] [Related]
5. The effect of somatostatin on plasma insulin and growth hormone levels in basal conditions and after glucagon in normal and acromegalic subjects. Massara F; Porzio G; Camanni F; Molinatti GM Acta Diabetol Lat; 1975; 12(3-4):219-31. PubMed ID: 1224905 [TBL] [Abstract][Full Text] [Related]
6. Effect of a somatostatin analog on insulin requirement and hormone levels in 6 insulin-dependent juvenile-onset diabetics subjected to artificial pancreas. Lenti G; Trovati M; Lorenzati R; Vitelli F; Tagliaferro V; Marocco A; Pagano G Acta Diabetol Lat; 1980; 17(1):9-14. PubMed ID: 6106342 [TBL] [Abstract][Full Text] [Related]
7. Development of specific and non-specific somatostatin analogs. Nakano T; Harano Y; Emura J; Kimura T; Sakakibara S; Shigeta Y Horm Metab Res; 1986 Feb; 18(2):98-102. PubMed ID: 2870971 [TBL] [Abstract][Full Text] [Related]
8. The diabetogenic action of somatostatin in healthy subjects and in maturity onset diabetics. Waldhäusl W; Bratusch-Marrain P; Dudczak R; Deutsch E J Clin Endocrinol Metab; 1977 May; 44(5):876-83. PubMed ID: 870515 [TBL] [Abstract][Full Text] [Related]
9. Effect of somatostatin and two of its analogues on basal and arginine-stimulated insulin and glucagon secretion in the dog. Buchs A; Märki F; Keller U Regul Pept; 1982 Aug; 4(3):117-26. PubMed ID: 6127755 [TBL] [Abstract][Full Text] [Related]
10. A comparison of the effect of levodopa and somatostatin on the plasma levels of growth hormone, insulin, glucagon and prolactin in acromegaly. Dunn PJ; Donald RA; Espiner EA Clin Endocrinol (Oxf); 1976 Mar; 5(2):167-74. PubMed ID: 1269163 [TBL] [Abstract][Full Text] [Related]
11. Selective effect of some somatostatin analogs on glucagon as opposed to insulin release in rats in vivo. Lins PE; Efendić S; Meyers CA; Coy DH; Schally A; Luft R Metabolism; 1980 Aug; 29(8):728-31. PubMed ID: 6105610 [TBL] [Abstract][Full Text] [Related]
12. Increase by somatostatin of the arginine induced rise in blood glucose in untreated insulin requiring diabetics. Waldhäusl W; Bratusch-Marrain P; Nowotny P Endokrinologie; 1979; 73(3):323-7. PubMed ID: 499100 [TBL] [Abstract][Full Text] [Related]
14. Dose-response study of the inhibiting effect of somatostatin on growth hormone and insulin secretion in normal subjects and acromegalic patients. Giustina G; Peracchi M; Reschini E; Panerai E; Pinto M Metabolism; 1975 Jul; 24(7):807-15. PubMed ID: 1138156 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of growth hormone and glucagon release by Phe-4-somatostatin in patients with acromegaly. Charro AL; Cabranes JA; Lafuente A; Diaz-Salgado C; Cordero M; Almoguera I; Comaru-Schally AM; Meyers CA; Coy DH; Schally AV Res Commun Chem Pathol Pharmacol; 1984 Sep; 45(3):432-44. PubMed ID: 6150529 [TBL] [Abstract][Full Text] [Related]
16. Human pancreatic growth hormone-releasing factor (hpGRF-44) in acromegaly before and after adenomectomy. Modifications induced by somatostatin (GHRIH) infusion. Arosio M; Ambrosi B; Guglielmino L; Faglia G J Endocrinol Invest; 1985 Oct; 8(5):449-53. PubMed ID: 2867112 [TBL] [Abstract][Full Text] [Related]
17. Effect of somatostatin and a glucagon-specific analog on glucose homeostasis during arginine infusion. Lien EL Metabolism; 1978 Sep; 27(9):1095-100. PubMed ID: 682972 [TBL] [Abstract][Full Text] [Related]
18. Effect of a long acting glucagon selective somatostatin analogue on plasma glucose, insulin and glucagon levels in the anaesthetized rat during arginine infusion. Lien E; Sarantakis D Diabetologia; 1979 Jul; 17(1):59-64. PubMed ID: 467854 [TBL] [Abstract][Full Text] [Related]
19. Effects of somatostatin on basal levels of plasma growth hormone and insulin in acromegalics: dose-response studies and attempted total growth hormone suppression. Christensen SE; Nerup J; Hansen AP; Lundbaek K J Clin Endocrinol Metab; 1976 May; 42(5):839-45. PubMed ID: 773950 [TBL] [Abstract][Full Text] [Related]
20. Non-selective inhibition of basal glucagon release by [D-Cys14]-analogues of somatostatin in the rat. Märki F; Kamber B; Rink H; Sieber P J Endocrinol; 1979 Jun; 81(3):315-23. PubMed ID: 469462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]